We show that Juglone and KPT6566 suppress proliferation and colony formation of CD44+CD133+ tumor-initiating Caco-2 cells in vitro, and hamper the tumorigenic capacity of CD44+CD133+ tumor-initiating Caco-2 cells in vivo. This evidence concerns the gene CD44 and neoplasm.